# Androcur Non-interventional Study Among Patients With Carcinoma of the Prostate

> **NCT00919022** · — · TERMINATED · sponsor: **Bayer** · enrollment: 194 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Cyproterone Acetate (Androcur, BAY94-8367)

## Key facts

- **NCT ID:** NCT00919022
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** —
- **Final completion:** 2011-08
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2012-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00919022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00919022, "Androcur Non-interventional Study Among Patients With Carcinoma of the Prostate". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00919022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*